Balancing Treg Biology, Profitability & Patient Needs to Drive Smart Indication Selection
- Highlighting the key considerations guide indication selection for Treg therapies
- Exploring the success of antigen specific Treg trafficking to key disease areas to effectively evaluate treatment efficacy and guide indication selection
- Assessing opportunities for leveraging Treg bystander effects to enhance immune modulation across multiple conditions
- Considering how preclinical model availability influences indication strategies, from narrow focus to broader applications